Cargando…

ICNIRP Statement on Diagnostic Devices Using Non-ionizing Radiation: Existing Regulations and Potential Health Risks

Use of non-ionizing radiation (NIR) for diagnostic purposes allows non-invasive assessment of the structure and function of the human body and is widely employed in medical care. ICNIRP has published previous statements about the protection of patients during medical magnetic resonance imaging (MRI)...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	ICNIRP Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515634/ https://www.ncbi.nlm.nih.gov/pubmed/28121732 http://dx.doi.org/10.1097/HP.0000000000000654

Ejemplares similares

A Closer Look at the Thresholds of Thermal Damage: Workshop Report by an ICNIRP Task Group
por: Sienkiewicz, Zenon, et al.
Publicado: (2016)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

ESR statement on radiation protection: globalisation, personalised medicine and safety (the GPS approach)
Publicado: (2013)

Statement of the Italian Association of Medical Physics (AIFM) task group on radiation dose monitoring systems
por: Ria, Francesco, et al.
Publicado: (2022)

Statement on the derivation of Health‐Based Guidance Values (HBGVs) for regulated products that are also nutrients
por: More, Simon, et al.
Publicado: (2021)

How to establish and use local diagnostic reference levels: an ESR EuroSafe Imaging expert statement
por: Damilakis, John, et al.
Publicado: (2023)

Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
por: Lee, Han Hee, et al.
Publicado: (2023)

Statement on the translocation potential by Pseudomonas chlororaphis MA342 in plants after seed treatment of cereals and peas and assessment of the risk to humans
por: Hernandez‐Jerez, Antonio F, et al.
Publicado: (2020)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

Statement on the revised targeted risk assessment for certain maximum residue levels for nicotine
Publicado: (2023)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

Statement on the dietary risk assessment for the proposed temporary maximum residue level for chlormequat in oyster mushrooms
Publicado: (2019)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
por: Kowalski, Marek L., et al.
Publicado: (2016)

Statement on the impact of the harmonised classification on the conclusion on the peer review of the pesticide risk assessment of the active substance flutianil
Publicado: (2018)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Statement concerning the review of the approval of the active substance ipconazole
Publicado: (2022)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Statement concerning the review of the approval of the active substance pirimicarb
Publicado: (2023)

Statement on the BfR opinion regarding the toxicity of 2‐chloroethanol
por: Borroto, Jorge, et al.
Publicado: (2022)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

Statement on how to interpret the QPS qualification on ‘acquired antimicrobial resistance genes’
por: Koutsoumanis, Konstantinos, et al.
Publicado: (2023)

Statement on the short‐term (acute) dietary risk assessment for the temporary maximum residue levels for nicotine in rose hips, teas and capers
Publicado: (2022)

Statement on the short‐term (acute) dietary risk assessment and evaluation of confirmatory data for certain maximum residue levels (MRLs) for thiacloprid
Publicado: (2023)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos
Publicado: (2019)

American College of Medical Genetics Statement on Diagnostic Testing for Uniparental Disomy
por: Shaffer, Lisa G., et al.
Publicado: (2001)

Attracting the next generation of radiologists: a statement by the European Society of Radiology (ESR)
Publicado: (2022)

EFSA statement on the review of the risks related to the exposure to the food additive titanium dioxide (E 171) performed by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES)
Publicado: (2019)

Statement on the available outcomes of the human health assessment in the context of the pesticides peer review of the active substance chlorpyrifos‐methyl
Publicado: (2019)

Vascular Ultrasound Statement from the Department of Cardiovascular Imaging of the Brazilian Society of Cardiology - 2019
por: dos Santos, Simone Nascimento, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kfdh9esbbhf0lnctjr36ub91s3